Drug may sharpen Surgeon's view during shoulder operations

NCT ID NCT05397652

Completed Symptom relief Sponsor: Nikola Matejcic Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether giving tranexamic acid (TXA) before shoulder arthroscopy improves the surgeon's view and reduces bleeding. 121 adults with rotator cuff tears received either TXA or a placebo. The main goal was to see if TXA makes the surgery clearer and safer.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: tranexamic acid
What this could lead to: If it works, this could make shoulder surgery safer and clearer for surgeons, potentially reducing complications and speeding up recovery.
What could go wrong: This is a small, single-center trial. Tranexamic acid carries a small risk of blood clots, and the benefits may not apply to all patients or surgeries.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMORRHAGE, SURGICAL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Blood Loss, Surgical Hemorrhage Rotator Cuff Injuries rotator cuff syndrome Shoulder Injuries

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEMORRHAGE, SURGICAL ROTATOR CUFF TEARS SHOULDER INJURIES

Contacts and locations

Locations

University orthopaedic and trauma hospital

Lovran, Primorje-Gorski Kotar County, 51415, Croatia

More trials for these conditions

Other studies related to the condition(s) this trial covers.